Cite
The Effect of Tafamidis on Circulating Endothelial Progenitor Cells in Patients with Transthyretin Cardiac Amyloidosis
MLA
Osnat, Itzhaki Ben Zadok, et al. “The Effect of Tafamidis on Circulating Endothelial Progenitor Cells in Patients with Transthyretin Cardiac Amyloidosis.” Cardiovascular Drugs and Therapy, vol. 36, no. 3, Sept. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........1451165f02835fcb4f7dc3df91e2c46d&authtype=sso&custid=ns315887.
APA
Osnat, I. B. Z., Dorit, L.-L., Tuvia, B.-G., Ashraf, H., Nili, S. P., Tali, S., Irit, K., Ilit, O., Ran, K., & Alon, E. (2021). The Effect of Tafamidis on Circulating Endothelial Progenitor Cells in Patients with Transthyretin Cardiac Amyloidosis. Cardiovascular Drugs and Therapy, 36(3).
Chicago
Osnat, Itzhaki Ben Zadok, Leshem-Lev Dorit, Ben-Gal Tuvia, Hamdan Ashraf, Schamroth Pravda Nili, Steinmetz Tali, Kandinov Irit, Ovadia Ilit, Kornowski Ran, and Eisen Alon. 2021. “The Effect of Tafamidis on Circulating Endothelial Progenitor Cells in Patients with Transthyretin Cardiac Amyloidosis.” Cardiovascular Drugs and Therapy 36 (3). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........1451165f02835fcb4f7dc3df91e2c46d&authtype=sso&custid=ns315887.